Skip to content

Clinical trials

Completed Phase 4 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 4 Status: Completed Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20041
20063
20072
20084
20092
20111
20122
20132
20142
20152
20163
20171
20192
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Taipei Veterans General Hospital, Taiwan2
Alexandria University1
Amgen1
Assistance Publique - Hôpitaux de Paris1
Azienda Ospedaliero, Universitaria Ospedali Riuniti1
Bristol-Myers Squibb1
CSA Medical, Inc.1
Celgene1
China Medical University, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms35
Carcinoma, Non-Small-Cell Lung11
Carcinoma, Renal Cell3
Head and Neck Neoplasms3
Breast Neoplasms2
Carcinoma2
Carcinoma, Hepatocellular2
Carcinoma, Large Cell2
Esophageal Neoplasms2
Hypopharyngeal Neoplasms2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.